Study: 26% of C. Diff Patients Received Only Unnecessary Antimicrobials
Researchers studied 246 patients with new-onset CDI diagnosed at Minneapolis Veterans Affairs Medical Center from January 2004 through December 2006. Two infectious disease physicians evaluated the use of non-CDI antimicrobials (those that are inactive against C. diff), which they defined as unnecessary if not fully indicated.
Data showed 57 percent of patients received non-CDI antimicrobials during and/or after their CDI treatment, and 77 percent received at least one unnecessary antimicrobial dose. Twenty-six percent of patients received only unnecessary antimicrobials.
More Articles on C. diff:Quidel Receives FDA Clearance for Handheld Molecular Diagnostic Test for C. Difficile
Illinois Publishes C. Diff, MRSA Data From Lab Tests for First Time
Study: Dog Correctly Detected C. Difficile in Patients
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Cigna serves as a beacon of hope for the ACA, expands into new markets: 4 things to know
- 6 key considerations before diving into bundled payments — Take it from a frontrunner ASC
- Inconsistencies among medical examiners skew firearm-related death data: 5 takeaways
- Total joint replacement in ASCs: 10 years & counting for Pacific Rim Outpatient Surgery Center — 5 things to know
- 10 largest ASC chains in the US